Long-term low-dose morphine for patients with moderate cancer pain is predominant factor effecting clinically meaningful pain reduction
ConclusionsAmong patients with moderate cancer pain, long-term low-dose morphine was safe and more effective than tramadol for clinically meaningful pain reduction, and patients were less likely to change the analgesic strategy.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Cancer Therapy | Constipation | International Medicine & Public Health | Morphine | Neurology | Neuroscience | Pain | Palliative | Palliative Care | Study | Tramadol | WHO